v3.25.4
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities of continuing operations:        
Net loss $ (5,420,195) $ (1,713,123) $ (1,071,845) $ (657,375)
Adjustments to reconcile net loss to cash used in operating activities:        
Stock based compensation and services 1,923,217 849,513 115,038  
Interest expense 46,807  
Provisions for contingencies 14,010 16,770  
Depreciation and amortization 18,228 206  
Impairment losses 56,536  
Gain/loss in foreign exchange transactions (4,724) (698)  
Changes in operating assets and liabilities:        
Accounts payable 330,132 305,214 41,141  
Income taxes, net (18,887)  
Inventories 151,167 (205,128)  
Trade receivable and other assets (41,728) (80,815) (3,566)  
Net cash used in operating activities (2,983,086) (846,948) (862,696)  
Cash flows from investing activities:        
Cash received from the merger transaction 2,857  
Acquisition of capital assets (67,304) (156,575)  
Net cash used in investing activities (67,304) (153,718)  
Cash flows from financing activities:        
Related party 167,241 (283,334) 638,545  
Net proceeds from sale of common stock 2,516,900 1,595,750 291,600  
Net cash provided by financing activities 2,684,141 1,312,416 930,145  
Effect of exchange rates on cash and cash equivalents 253 (8,347) (74)  
Net increase in cash and cash equivalents (365,996) 303,403 67,375  
Cash and cash equivalents at beginning of period 396,216 92,813 25,438  
Cash and cash equivalents at end of period $ 30,220 $ 396,216 $ 92,813 $ 25,438